OUTLOOK THERAPEUTICS INC: Istoricul versiunilor

2 octombrie 2024

• actualăprec 16:532 octombrie 2024 16:53‎ 127.0.0.1 discuție‎ 1.416 octeți +8‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 20:1918 septembrie 2024 20:19‎ Admin discuție contribuții‎ 1.408 octeți +1.408‎ Pagină nouă: Pagina dedicata companiei OUTLOOK THERAPEUTICS INC listata cu simbolul US.OTLK ==Descriere companie== Outlook Therapeutics, Inc. (https://outlooktherapeutics.com/) is a late clinical-stage biopharmaceutical company. The Company is engaged in developing ophthalmic formulation of bevacizumab for use in retinal indications. bevacizumab is a full-length, humanized anti-VEGF (Vascular Endothelial Growth Factor) recombinant monoclonal antibody (mAb), that inhibits VEGF and associa...